Skip to main content
$16.07 $0.01 (0.1%)

01:00 PM EDT on 05/30/23


CAPS Rating: No stars

Current Price $16.07 Mkt Cap $6.7B
Open $16.13 P/E Ratio -70.38
Prev. Close $16.06 Div. (Yield) $0.00 (0.0%)
Daily Range $16.00 - $16.40 Volume 527,263
52-Wk Range $6.71 - $27.07 Avg. Daily Vol. 2,289,009


How do you think NASDAQ:RCM will perform against the market?

Add Stock to CAPS Watchlist

All Players

34 Outperform
2 Underperform

All-Star Players

6 Outperform
0 Underperform

Wall Street

0 Outperform
0 Underperform

Top NASDAQ:RCM Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Top Bull Pitch

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches below!

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!


Fools bullish on NASDAQ:RCM are also bullish on:

Fools bearish on NASDAQ:RCM are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about RCM.


Member Avatar Nuro (38.65) Submitted: 4/10/2015 6:04:11 PM : Outperform Start Price: $5.65 NASDAQ:RCM Score: +83.84

appeared on magic formula investing


Member Avatar 240247479 (< 20) Submitted: 3/25/2014 2:54:09 PM : Outperform Start Price: $7.96 NASDAQ:RCM Score: -23.78

AH's revenue cycle management (RCM) service helps hospitals improve their operating margins. The company has had a couple of unlucky, non-recurring events disrupt its business. First, a notebook computer with unencrypted patient data was stolen over a year ago in MN. This led to the some unflattering business tactics being publicly debated, the lose of a contract and a fine from the MN AG. Then, shortly thereafter, the company announced it would have to restate its financials due to issues covering revenue recognition. In short, the stock is unloved and underfollowed--an fallen angel. However, in an update report delivered in Nov. 2013, new management disclosed that the restatements, when completed, would have no impact on cash flows. Moreover, in the time since the last reported balance sheet, AH's cash balance had grown from < $200m to > $220m, indicating solid business trends. Further, the company has not experienced any further client attrition due to the delay in financial reporting and issues in MN. RCM is a very attractive business in health care as billing becomes more complex. AH appears undervalued, especially relative to its peers (although I am not a fan of relative values). Management agrees--announcing a buyback will be implemented as soon as the financial restatement is complete. This was suppose to happen about 10 tens ago, but was delayed as it continues to take time, money and manpower to complete. The stock do not react to the announcement, a further indication it probably has bottomed here.


Member Avatar BicaChica (82.99) Submitted: 8/25/2010 1:43:29 AM : Outperform Start Price: $9.51 NASDAQ:RCM Score: -231.64



Find the members with the highest scoring picks in RCM.

Score Leader


tangyblowfish (< 20) Score: +541.28

The Score Leader is the player with the highest score across all their picks in RCM.

Member Name Member
Call Time
Score Commentary
tangyblowfish < 20 12/30/2016 Outperform 1Y $2.20 +629.55% +88.27% +541.28 0 Comment
TMFConan 84.89 10/3/2016 Outperform 5Y $2.44 +557.79% +94.71% +463.07 0 Comment
AAOI 95.33 1/30/2017 Outperform 3Y $2.50 +542.00% +84.17% +457.83 0 Comment
pnouri 48.84 8/3/2010 Underperform 5Y $11.50 +39.57% +273.80% +234.24 0 Comment
SconiFool 70.54 5/28/2015 Outperform 1Y $5.38 +198.33% +97.91% +100.41 0 Comment
Nuro 38.65 4/13/2015 Outperform 1Y $5.65 +184.07% +100.23% +83.84 1 Comment
dsherid2 32.80 2/9/2015 Outperform 1Y $5.85 +174.36% +105.22% +69.14 0 Comment
GoldMiner20 < 20 12/5/2022 Outperform 5Y $9.74 +64.78% +4.03% +60.75 0 Comment
Tangoko < 20 1/10/2023 Underperform 3M $12.67 +26.68% +7.86% -18.82 0 Comment
smgod1 < 20 8/7/2020 Outperform 5Y $15.16 +5.87% +26.42% -20.55 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for RCM.